The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection

HIV Medicine

Volumn 15, Issue 10, 2014, Pages 587-594

  Guaraldi, G ^a   Stentarelli, C ^a   Zona, S ^a   Santoro, A ^a   Beghetto, B ^a   Carli, F ^a   Orlando, G ^a   Franceschetto, A ^a   Casolo, A ^a   Mussini, C ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Antropometry; Body composition; Body fat changes; Lipoatrophy; Lipodystrophy; Lipohypetrophy

Indexed keywords

ANTIRETROVIRUS AGENT; INTEGRASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGED; AGING; ANTHROPOMETRY; ARTICLE; BODY FAT; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSESSMENT; DRUG EXPOSURE; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS; FEMALE; GENERALIZED ESTIMATING EQUATION REGRESSION MODEL; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTRAABDOMINAL FAT; ITALY; LIPOATROPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; COMPLICATION; DRUG EFFECTS; HIV INFECTIONS; LEG; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; RADIOGRAPHY; WAIST CIRCUMFERENCE;

ABSORPTIOMETRY, PHOTON; ADULT; ANTI-RETROVIRAL AGENTS; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS INDEX; FEMALE; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INTRA-ABDOMINAL FAT; ITALY; LEG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; WAIST CIRCUMFERENCE;

EID: 84911368382     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12159     Document Type: Article

References (24)

1. Mocroft A, Ledergerber B, Katlama C etal. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362: 22-29.
2. Palella F, Delaney K, Moorman A etal. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853-860.
3. Bhaskaran K, Hamouda O, Sannes M etal. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA 2008; 300: 51-59.
4. Carr A, Samaras K, Burton S etal. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12: F51-F58.
5. Bacchetti P, Gripshover B, Grunfeld C etal. Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr 2005; 40: 121-131.
6. Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Fat distribution in women with HIV infection. J Acquir Immune Defic Syndr 2006; 42: 562-571.
7. Wohl D, Scherzer R, Heymsfield S etal. The associations of regional adipose tissue with lipid and lipoprotein levels in HIV-infected men. J Acquir Immune Defic Syndr 2008; 48: 44-52.
8. Grunfeld C, Rimland D, Gibert C etal. Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study. J Acquir Immune Defic Syndr 2007; 46: 283-290.
9. Lichtenstein K, Ward D, Moorman A etal. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 2001; 15: 1389-1398.
10. Ribera E, Paradineiro J, Curran A etal. Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study). HIV Clin Trials 2008; 9: 407-417.
11. Gopinath R, Hutcheon M, Cheema-Dhadli S, Halperin M. Chronic lactic acidosis in a patient with acquired immunodeficiency syndrome and mitochondrial myopathy: biochemical studies. J Am Soc Nephrol 1992; 3: 1212-1219.
12. Kitahata M, Gange S, Abraham A etal. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360: 1815-1826.
13. Mallon PW, Wand H, Law M etal. Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia. J Acquir Immune Defic Syndr 2005; 38: 156-162.
14. He Q, Engelson ES, Ionescu G, Glesby MJ, Albu JB, Kotler DP. Insulin resistance, hepatic lipid and adipose tissue distribution in HIV-infected men. Antivir Ther 2008; 13: 423-428.
15. Lo J, Abbara S, Rocha-Filho JA, Shturman L, Wei J, Grinspoon SK. Increased epicardial adipose tissue volume in HIV-infected men and relationships to body composition and metabolic parameters. AIDS 2010; 24: 2127-2130.
16. Albu JB, Kenya S, He Q etal. Independent associations of insulin resistance with high whole-body intermuscular and low leg subcutaneous adipose tissue distribution in obese HIV-infected women. Am J Clin Nutr 2007; 86: 100-106.
17. Torriani M, Thomas BJ, Barlow RB, Librizzi J, Dolan S, Grinspoon S. Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution. J Appl Physiol 2006; 100: 609-614.
18. Caron-Debarle M, Lagathu C, Boccara F, Vigouroux C, Capeau J. HIV-associated lipodystrophy: from fat injury to premature aging. Trends Mol Med 2010; 16: 218-229.
19. Lewis CE, Jacobs DR, McCreath H etal. Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol 2000; 151: 1172-1181.
20. Guaraldi G, Orlando G, Squillace N etal. Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy. HIV Clin Trials 2006; 7: 97-106.
21. Palella FJ, Cole SR, Chmiel JS etal. Anthropometrics and examiner-reported body habitus abnormalities in the multicenter AIDS cohort study. Clin Infect Dis 2004; 38: 903-907.
22. Grunfeld C, Saag M, Cofrancesco J Jr etal. Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy. AIDS 2010; 24: 1717-1726.
23. Brown TT, Xu X, John M etal. Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: a substudy of the Multicenter AIDS Cohort Study. AIDS Res Ther 2009; 13: 6-8.
24. Nguyen A, Calmy A, Schiffer V etal. Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006. HIV Med 2008; 9: 142-150.